However, reports of the prognostic value of vascularization in human CRCC have shown either no effect on patient survival, better survival or worse prognosis [24-26]; these discrepancies may be the consequence of vessel size and/or the co-existence of different vessels depending on the expressed markers CD31 and CD34 [27]. The gene discussed is PECAM1; the disease is chromophobe renal cell carcinoma.